ATE324880T1 - Behandlung von mastalgie mit4-hydroxy-tamoxifen - Google Patents
Behandlung von mastalgie mit4-hydroxy-tamoxifenInfo
- Publication number
- ATE324880T1 ATE324880T1 AT03813146T AT03813146T ATE324880T1 AT E324880 T1 ATE324880 T1 AT E324880T1 AT 03813146 T AT03813146 T AT 03813146T AT 03813146 T AT03813146 T AT 03813146T AT E324880 T1 ATE324880 T1 AT E324880T1
- Authority
- AT
- Austria
- Prior art keywords
- mastalgia
- tamoxifen
- hydroxy
- treatment
- hydroxy tamoxifen
- Prior art date
Links
- DODQJNMQWMSYGS-QPLCGJKRSA-N 4-[(z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-phenylbut-1-en-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 DODQJNMQWMSYGS-QPLCGJKRSA-N 0.000 title abstract 3
- 206010006298 Breast pain Diseases 0.000 abstract 1
- 208000006662 Mastodynia Diseases 0.000 abstract 1
- 230000001476 alcoholic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43395902P | 2002-12-18 | 2002-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE324880T1 true ATE324880T1 (de) | 2006-06-15 |
Family
ID=32595255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03813146T ATE324880T1 (de) | 2002-12-18 | 2003-12-15 | Behandlung von mastalgie mit4-hydroxy-tamoxifen |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7786172B2 (https=) |
| EP (1) | EP1572178B1 (https=) |
| JP (1) | JP4938237B2 (https=) |
| AT (1) | ATE324880T1 (https=) |
| AU (1) | AU2003303033B2 (https=) |
| CA (1) | CA2509660C (https=) |
| CY (1) | CY1106131T1 (https=) |
| DE (1) | DE60305068T2 (https=) |
| DK (1) | DK1572178T3 (https=) |
| ES (1) | ES2263072T3 (https=) |
| MX (1) | MXPA05006526A (https=) |
| NZ (1) | NZ540494A (https=) |
| PT (1) | PT1572178E (https=) |
| SI (1) | SI1572178T1 (https=) |
| WO (1) | WO2004054557A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60327363D1 (de) * | 2002-12-18 | 2009-06-04 | Besins Int Lab | Verringerung der dichte des brustgewebes durch 4-hydroxy tamoxifen |
| ES2456958T3 (es) * | 2003-04-01 | 2014-04-24 | Besins Healthcare Luxembourg Sarl | Formulaciones para prevención y tratamiento de cáncer de seno con 4-hidroxi tamoxifen |
| JP4682129B2 (ja) * | 2003-06-09 | 2011-05-11 | アセンド セラピュティクス インコーポレイテッド | ４−ヒドロキシタモキシフェンによる過剰瘢痕化の治療及び予防 |
| US7968532B2 (en) * | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
| US7507769B2 (en) * | 2004-03-22 | 2009-03-24 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| EP1579856A1 (en) * | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| US20050208139A1 (en) * | 2004-03-22 | 2005-09-22 | Ascend Therapeutics, Inc. | Chemically stable compositions of 4-hydroxy tamoxifen |
| PT1748770E (pt) * | 2004-03-22 | 2008-07-16 | Besins Int Lab | Tratamento e prevenção de doença benigna da mama com 4-hidroxi-tamoxifeno |
| EP1647271A1 (en) * | 2004-10-14 | 2006-04-19 | Laboratoires Besins International | 4-Hydroxy tamoxifen gel formulations |
| EA011295B1 (ru) * | 2004-10-14 | 2009-02-27 | Лаборатуар Безен Энтернасьональ | Рецептура геля с 4-гидрокситамоксифеном |
| CN101282646B (zh) * | 2005-07-12 | 2013-03-27 | Dmi生物科学公司 | 治疗疾病的方法和产品 |
| ES2523769T3 (es) | 2009-06-22 | 2014-12-01 | Ampio Pharmaceuticals, Inc. | Procedimiento de tratamiento de enfermedades |
| EP2934546A4 (en) | 2012-12-19 | 2016-06-22 | Ampio Pharmaceuticals Inc | METHOD OF DISEASE TREATMENT |
| TWI793165B (zh) | 2017-09-11 | 2023-02-21 | 美商阿托薩醫療公司 | 製造及使用因多昔芬(endoxifen)之方法 |
| MX2022000203A (es) | 2019-07-03 | 2022-03-22 | Atossa Therapeutics Inc | Composiciones de liberacion sostenida de endoxifeno. |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2558373B1 (fr) * | 1984-01-20 | 1987-07-03 | Mauvais Jarvis Pierre | Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee |
| ATE80152T1 (de) | 1987-04-21 | 1992-09-15 | Heumann Pharma Gmbh & Co | Stabile loesungsmitteladdukte von z-1-(p-betadimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl) 2-phenylbut-1-en. |
| US5045553A (en) | 1987-06-24 | 1991-09-03 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter |
| DE3836862A1 (de) | 1988-10-27 | 1990-05-03 | Schering Ag | Mittel zur transdermalen applikation von steroidhormonen |
| US5189212A (en) * | 1990-09-07 | 1993-02-23 | University Of Georgia Research Foundation, Inc. | Triarylethylene carboxylic acids with estrogenic activity |
| TW218849B (https=) | 1991-05-17 | 1994-01-11 | Bristol Myers Squibb Co | |
| US5613958A (en) * | 1993-05-12 | 1997-03-25 | Pp Holdings Inc. | Transdermal delivery systems for the modulated administration of drugs |
| US5720963A (en) | 1994-08-26 | 1998-02-24 | Mary Kay Inc. | Barrier disruption treatments for structurally deteriorated skin |
| IL120266A (en) * | 1996-02-28 | 2005-05-17 | Pfizer | Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions |
| IL120268A0 (en) * | 1996-02-28 | 1997-06-10 | Pfizer | Use of (E)-1-[4'-(2-alkylaminoethioxy)phenyl]1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions |
| US6548491B2 (en) * | 1997-12-24 | 2003-04-15 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| US6013270A (en) | 1998-04-20 | 2000-01-11 | The Procter & Gamble Company | Skin care kit |
| NZ520015A (en) * | 1999-12-16 | 2003-03-28 | Dermatrends Inc | Hydroxide-releasing agents as skin permeation enhancers |
| DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| EP1177787A3 (en) | 2000-07-28 | 2003-09-10 | Pfizer Products Inc. | Use of an estrogen agonist/antagonist for treating cataracts |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| DE10054294A1 (de) * | 2000-11-02 | 2002-05-16 | Heinrich Wieland | Topische Behandlung bei der Mastalgie |
| ATE288303T1 (de) | 2000-11-30 | 2005-02-15 | Pfizer Prod Inc | Östrogen agonist-antagonist und testosteron enthaltende zusammensetzung zur behandlung abnehmender testosteronspiegel |
| EP1411922A1 (en) | 2001-07-31 | 2004-04-28 | Pfizer Products Inc. | Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| DK1317921T3 (da) | 2001-12-07 | 2009-12-21 | Besins Mfg Belgium | Farmaceutisk sammensætning i form af en gel eller oplösning med dihydrotestosteron, fremgangsmåde til fremstilling og anvendelser heraf |
| DE60327363D1 (de) | 2002-12-18 | 2009-06-04 | Besins Int Lab | Verringerung der dichte des brustgewebes durch 4-hydroxy tamoxifen |
| ES2456958T3 (es) | 2003-04-01 | 2014-04-24 | Besins Healthcare Luxembourg Sarl | Formulaciones para prevención y tratamiento de cáncer de seno con 4-hidroxi tamoxifen |
| JP4682129B2 (ja) | 2003-06-09 | 2011-05-11 | アセンド セラピュティクス インコーポレイテッド | ４−ヒドロキシタモキシフェンによる過剰瘢痕化の治療及び予防 |
| US7968532B2 (en) | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
| US7507769B2 (en) | 2004-03-22 | 2009-03-24 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| US20050208139A1 (en) | 2004-03-22 | 2005-09-22 | Ascend Therapeutics, Inc. | Chemically stable compositions of 4-hydroxy tamoxifen |
| EP1579856A1 (en) | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| EP1647271A1 (en) | 2004-10-14 | 2006-04-19 | Laboratoires Besins International | 4-Hydroxy tamoxifen gel formulations |
-
2003
- 2003-12-15 MX MXPA05006526A patent/MXPA05006526A/es active IP Right Grant
- 2003-12-15 SI SI200330296T patent/SI1572178T1/sl unknown
- 2003-12-15 DK DK03813146T patent/DK1572178T3/da active
- 2003-12-15 JP JP2004560487A patent/JP4938237B2/ja not_active Expired - Lifetime
- 2003-12-15 AU AU2003303033A patent/AU2003303033B2/en not_active Expired
- 2003-12-15 WO PCT/EP2003/015028 patent/WO2004054557A2/en not_active Ceased
- 2003-12-15 AT AT03813146T patent/ATE324880T1/de active
- 2003-12-15 CA CA2509660A patent/CA2509660C/en not_active Expired - Lifetime
- 2003-12-15 EP EP03813146A patent/EP1572178B1/en not_active Expired - Lifetime
- 2003-12-15 US US10/734,640 patent/US7786172B2/en active Active
- 2003-12-15 DE DE60305068T patent/DE60305068T2/de not_active Expired - Lifetime
- 2003-12-15 NZ NZ540494A patent/NZ540494A/en not_active IP Right Cessation
- 2003-12-15 ES ES03813146T patent/ES2263072T3/es not_active Expired - Lifetime
- 2003-12-15 PT PT03813146T patent/PT1572178E/pt unknown
-
2006
- 2006-07-27 CY CY20061101041T patent/CY1106131T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2263072T3 (es) | 2006-12-01 |
| AU2003303033B2 (en) | 2009-06-04 |
| HK1075403A1 (en) | 2005-12-16 |
| MXPA05006526A (es) | 2006-02-17 |
| SI1572178T1 (sl) | 2006-10-31 |
| JP4938237B2 (ja) | 2012-05-23 |
| DE60305068D1 (de) | 2006-06-08 |
| WO2004054557A3 (en) | 2004-08-05 |
| US20050032909A1 (en) | 2005-02-10 |
| US7786172B2 (en) | 2010-08-31 |
| CY1106131T1 (el) | 2011-06-08 |
| EP1572178A2 (en) | 2005-09-14 |
| JP2006514949A (ja) | 2006-05-18 |
| DE60305068T2 (de) | 2007-01-11 |
| CA2509660C (en) | 2011-08-30 |
| EP1572178B1 (en) | 2006-05-03 |
| WO2004054557A2 (en) | 2004-07-01 |
| CA2509660A1 (en) | 2004-07-01 |
| DK1572178T3 (da) | 2006-09-11 |
| NZ540494A (en) | 2007-05-31 |
| PT1572178E (pt) | 2006-09-29 |
| AU2003303033A1 (en) | 2004-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE324880T1 (de) | Behandlung von mastalgie mit4-hydroxy-tamoxifen | |
| WO2004054558A3 (en) | Reduction of breast density with 4-hydroxy tamoxifen | |
| IL258702B (en) | A pump system for use with organ care systems | |
| EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
| ATE373474T1 (de) | Substituierte 2-aminotetraline zur behandlung von depressionen | |
| SE0101387D0 (sv) | Novel compounds | |
| CZ2006579A3 (cs) | Kožní mikroaktivační systém | |
| ATE296094T1 (de) | Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen | |
| DK1797053T3 (da) | Phenothiazinium-forbindelse til sårheling | |
| DE502007003850D1 (de) | Gel zur Behandlung von Wunden | |
| DE602004017871D1 (de) | Zubereitungen zur behandlung von arthritischen erscheinungen | |
| DE602006010442D1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen | |
| HUP0200152A2 (hu) | KQT1 csatornák gátlóinak alkalmazása parazita férgek és ektoparaziták által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására | |
| ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
| ATE304854T1 (de) | Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne | |
| PT1276763E (pt) | Proteinas anti-congelantes sua producao e utilizacao | |
| BRPI0415187A (pt) | composição, método para matar bactérias, e, usos de composição e de bacteriófago | |
| DE50111407D1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
| DE602004025683D1 (de) | Therapeutische zubereitung für autoimmune erkrankungen | |
| DE60220825D1 (de) | Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks | |
| DK1537132T3 (da) | Salt af mortin-6-glucuronid | |
| PL369331A1 (pl) | Środek antyseptyczny do ran i błon śluzowych | |
| CY1110499T1 (el) | Παρασκευασματα γελης 4-υδροξυ ταμοξιφενης | |
| ITMI20041871A1 (it) | Uso di santoreggia satureja montana o dei suoi estratti per la preparazione di medicamenti per il trattamento dell'eiaculazione precoce | |
| EA200501059A1 (ru) | Способ защиты кожи |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1572178 Country of ref document: EP |